Mixed neuromuscular block: the effect of precurarization

Area of Science:

• Anesthesiology
• Pharmacology
• Neuromuscular blockade

Background:

• Suxamethonium is a common neuromuscular blocking agent.
• Precurarisation is sometimes used to mitigate side effects.
• The interaction between precurarising agents and suxamethonium requires further investigation.

Purpose of the Study:

• To investigate the effects of small doses of pancuronium, curare (d-tubocurarine), and gallamine on the neuromuscular blockade induced by suxamethonium.
• To assess the impact of these precurarising agents on the duration and degree of neuromuscular blockade.

Main Methods:

• Neuromuscular blockade was studied using train-of-four stimulation.
• Patients received a standard dose of suxamethonium (1 mg/kg).
• Pretreatment involved small doses of pancuronium, d-tubocurarine, or gallamine.

Main Results:

• Pretreatment with d-tubocurarine and gallamine reduced the duration of suxamethonium-induced neuromuscular blockade.
• Pancuronium pretreatment increased the duration of the neuromuscular blockade.
• The competitive neuromuscular blockade observed was mild and did not lead to postoperative muscle weakness.

Conclusions:

• The choice of precurarising agent significantly influences the duration of suxamethonium blockade.
• d-Tubocurarine and gallamine may offer benefits in shortening suxamethonium's action.
• Pancuronium should be used cautiously as a precurarising agent with suxamethonium due to potential prolongation of blockade.